SCHEMBL23735771

SCHEMBL23735771

CCC(=O)/C=C/CN(C)CC(=O)N(CC)CC

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21610088 0.91
SCHEMBL20326197 0.88
SCHEMBL21794811 0.86 ALDH1A1 (0.32)
SCHEMBL24337264 0.85
SCHEMBL20326367 0.80 LMNA (0.33) LMNA
SCHEMBL21741220 0.76 POLB (0.37)
SCHEMBL20334812 0.76 CHRNB2 (0.31)
SCHEMBL22880898 0.76
SCHEMBL20315045 0.75
SCHEMBL20326205 0.73 MEN1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3558955-B1 BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER AMGEN INC (US) 2021-08-11 EP disclosed